| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |